BLISS GVS PHARMA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Bliss GVS Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.13₹ 0.2
As on Oct 31, 2025, 4:01 PM IST
Bliss GVS Pharma Price Performance
Today's LowToday's High
₹156.10₹158.70
₹156.45
52 Weeks' Low52 Weeks' High
₹105.05₹190.65
₹156.45
Open Price
₹156.10
Prev. Close
₹156.25
Volume
12,785
Over the last 5 years, the share price of Bliss GVS Pharma has declined 1.47% CAGR. Over the past year, the corresponding return has been 26.78%.
Bliss GVS Pharma’s current P/E of 15.51x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Bliss GVS Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Bliss GVS Pharma | 2.22 | 2.25 | -11.38 | 32.81 | 26.78 | 27.49 | -1.47 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Bliss GVS Pharma has gained 26.78% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Bliss GVS Pharma has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Bliss GVS Pharma Financials
Bliss GVS Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 153.53 | 153.83 |
| 10 | 153.31 | 153.66 |
| 20 | 153.38 | 153.62 |
| 50 | 155.5 | 154.47 |
| 100 | 156.17 | 152.45 |
| 200 | 144.29 | 146.64 |
Bliss GVS Pharma Share Holding Pattern
In the latest quarter, Bliss GVS Pharma saw a drop in promoter holding to 35.39%, while DII stake decreased to 5.98%, FII holding rose to 13.27%, and public shareholding moved down to 45.36% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Bliss GVS Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 29, 2025, 9:21 PM IST | Bliss GVS Pharma - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For Th |
| Oct 11, 2025, 12:19 AM IST | Bliss GVS Pharma - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Oct 07, 2025, 1:21 AM IST | Bliss GVS Pharma - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosu |
| Oct 07, 2025, 12:01 AM IST | Bliss GVS Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 01, 2025, 12:27 AM IST | Bliss GVS Pharma - Announcement under Regulation 30 (LODR)-Change in Management |
About Bliss GVS Pharma
Bliss GVS Pharma Ltd. is a Public Limited Listed company incorporated on 11/12/1984 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1984PLC034771 and registration number is 034771. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 667.20 Cr. and Equity Capital is Rs. 10.54 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address102, Hyde Park, Saki Vihar Road, Mumbai Maharashtra 400072
- Contact
Management
- Mr. Nandkumar K ChodankarChairman & Ind.Director
- Mr. Gagan Harsh SharmaManaging Director
- Dr. Vibha Gagan SharmaWhole Time Director
- Mrs. Shruti Vishal RaoWhole Time Director
- Mr. Santosh L ParabIndependent Director
- Ms. Shilpa BhatiaIndependent Woman Director
FAQs on Bliss GVS Pharma Share Price
What is the share price of Bliss GVS Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bliss GVS Pharma is ₹156.45 as on Oct 31, 2025.
What kind of stock is Bliss GVS Pharma?
The Bliss GVS Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Bliss GVS Pharma?
The market cap of Bliss GVS Pharma is ₹1,653.50 Cr as on Oct 31, 2025.
What are today's High and Low prices of Bliss GVS Pharma?
Today’s highest and lowest price of Bliss GVS Pharma are ₹158.70 and ₹156.10.
What are the 52 Week High and 52 Week Low of Bliss GVS Pharma?
The 52-week high/low is the highest and lowest price at which Bliss GVS Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Bliss GVS Pharma is ₹190.65 and 52-week low of Bliss GVS Pharma is ₹105.05 as on Oct 31, 2025.
How has the Bliss GVS Pharma performed historically in terms of returns?
The Bliss GVS Pharma has shown returns of 0.13% over the past day, 2.25% for the past month, -11.38% over 3 months, 26.78% over 1 year, 27.49% across 3 years, and -1.47% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Bliss GVS Pharma?
P/E ratio of and PB ratio of Bliss GVS Pharma are 15.51 and 1.64 on Oct 31, 2025. While the company gives a dividend yield of 0.32 per annum.
✕
Market Pulse